We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
General Motors (GM) Q3 Earnings & Revenues Beat Estimates
Read MoreHide Full Article
General Motors Company (GM - Free Report) reported third-quarter 2018 adjusted earnings per share of $1.87, up 41.7% from the prior-year quarter. The bottom line also surpassed the Zacks Consensus Estimate of $1.26. The quarter witnessed robust performance across all new full-size trucks and crossovers in North America.
General Motors reported revenues of $35.8 billion, up 6.4% from the year-ago quarter figure. Further, revenues surpassed the Zacks Consensus Estimate of $34.2 billion.
During the last reported quarter, total sales for the wholesale unit increased to 1.13 million from 1.08 million in the third quarter of 2017. Worldwide retail unit sales decreased to 1.98 million from 2.32 million in the year-ago quarter. This automaker’s global market share was 8.6% during the reported quarter, reflecting a decline from 10% in the year-ago quarter.
General Motors Company Price, Consensus and EPS Surprise
GM North America (“GMNA”) generated net sales and revenues of $27.7 billion during the third quarter of 2018, up from $24.8 billion recorded in third-quarter 2017.
GM International’s (“GMI”) net sales and revenues were $4.6 billion, declining from $5.6 billion in the year-ago quarter.
GM Financial generated net sales and revenues of $3.5 billion during the quarter under review, reflecting an increase from $3.2 billion recorded in the year-ago quarter.
Financial Position
General Motors had cash and cash equivalents of $18.4 billion as of Sep 30, 2018, compared with $15.5 billion as of Dec 31, 2017.
Adjusted automotive free cash flow during the reported quarter was $396 million versus $1.2 billion of free cash used in the prior-year quarter.
General Motors currently carries a Zacks Rank #3 (Hold).
Allison Transmission has an expected long-term growth rate of 10%. Over the past six months, shares of the company have surged 13.4%.
Advance Auto Parts has an expected long-term growth rate of 12.3%. Over the past six months, shares of the company have risen 44.1%.
AutoZone has an expected long-term growth rate of 12.2%. Over the past six months, shares of the company have risen 19.7%.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
Image: Bigstock
General Motors (GM) Q3 Earnings & Revenues Beat Estimates
General Motors Company (GM - Free Report) reported third-quarter 2018 adjusted earnings per share of $1.87, up 41.7% from the prior-year quarter. The bottom line also surpassed the Zacks Consensus Estimate of $1.26. The quarter witnessed robust performance across all new full-size trucks and crossovers in North America.
General Motors reported revenues of $35.8 billion, up 6.4% from the year-ago quarter figure. Further, revenues surpassed the Zacks Consensus Estimate of $34.2 billion.
During the last reported quarter, total sales for the wholesale unit increased to 1.13 million from 1.08 million in the third quarter of 2017. Worldwide retail unit sales decreased to 1.98 million from 2.32 million in the year-ago quarter. This automaker’s global market share was 8.6% during the reported quarter, reflecting a decline from 10% in the year-ago quarter.
General Motors Company Price, Consensus and EPS Surprise
General Motors Company Price, Consensus and EPS Surprise | General Motors Company Quote
Segment Results
GM North America (“GMNA”) generated net sales and revenues of $27.7 billion during the third quarter of 2018, up from $24.8 billion recorded in third-quarter 2017.
GM International’s (“GMI”) net sales and revenues were $4.6 billion, declining from $5.6 billion in the year-ago quarter.
GM Financial generated net sales and revenues of $3.5 billion during the quarter under review, reflecting an increase from $3.2 billion recorded in the year-ago quarter.
Financial Position
General Motors had cash and cash equivalents of $18.4 billion as of Sep 30, 2018, compared with $15.5 billion as of Dec 31, 2017.
Adjusted automotive free cash flow during the reported quarter was $396 million versus $1.2 billion of free cash used in the prior-year quarter.
General Motors currently carries a Zacks Rank #3 (Hold).
A few better-ranked stocks in the auto space are Allison Transmission Holdings, Inc. (ALSN - Free Report) , Advance Auto Parts, Inc. (AAP - Free Report) and AutoZone, Inc. (AZO - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Allison Transmission has an expected long-term growth rate of 10%. Over the past six months, shares of the company have surged 13.4%.
Advance Auto Parts has an expected long-term growth rate of 12.3%. Over the past six months, shares of the company have risen 44.1%.
AutoZone has an expected long-term growth rate of 12.2%. Over the past six months, shares of the company have risen 19.7%.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
See them today for free >>